484 related articles for article (PubMed ID: 28530543)
1. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
3. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
Li W; Sun X
Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
[TBL] [Abstract][Full Text] [Related]
5. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
[TBL] [Abstract][Full Text] [Related]
6. Smart Drug Delivery Systems in Cancer Therapy.
Unsoy G; Gunduz U
Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
[TBL] [Abstract][Full Text] [Related]
7. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
Ishida T; Kiwada H
Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
9. A Computational/Experimental Assessment of Antitumor Activity of Polymer Nanoassemblies for pH-Controlled Drug Delivery to Primary and Metastatic Tumors.
Curtis LT; Rychahou P; Bae Y; Frieboes HB
Pharm Res; 2016 Oct; 33(10):2552-64. PubMed ID: 27356524
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in drug delivery systems for enhancing drug penetration into tumors.
He B; Sui X; Yu B; Wang S; Shen Y; Cong H
Drug Deliv; 2020 Dec; 27(1):1474-1490. PubMed ID: 33100061
[TBL] [Abstract][Full Text] [Related]
11. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
[TBL] [Abstract][Full Text] [Related]
12. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. Ligand-modified Biopolymeric Nanoparticles as Efficient Tools for Targeted Cancer Therapy.
Kouchakzadeh H; Soudi T; Aghda NH; Shojaosadati SA
Curr Pharm Des; 2017; 23(35):5336-5348. PubMed ID: 28552063
[TBL] [Abstract][Full Text] [Related]
15. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites.
Attia MF; Anton N; Wallyn J; Omran Z; Vandamme TF
J Pharm Pharmacol; 2019 Aug; 71(8):1185-1198. PubMed ID: 31049986
[TBL] [Abstract][Full Text] [Related]
16. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
18. pH-sensitive drug-delivery systems for tumor targeting.
He X; Li J; An S; Jiang C
Ther Deliv; 2013 Dec; 4(12):1499-510. PubMed ID: 24304248
[TBL] [Abstract][Full Text] [Related]
19. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
20. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]